Global Cell and Gene Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Description

Gene therapy (gene therapy) refers to the introduction of foreign normal genes into target cells to correct or compensate for diseases caused by defects and abnormal genes in order to achieve therapeutic purposes. It also includes the application of technology such as transgenes, that is, inserting foreign genes into appropriate recipient cells of patients through gene transfer technology, so that the products made by foreign genes can treat certain diseases. Broadly speaking, gene therapy can also include measures and new technologies taken from the DNA level to treat certain diseases. Cell therapy is a brand-new drug development model. In this type of therapy, immune cell therapy has proved to have the most potential. Now researchers have demonstrated its clinical benefits in the treatment of cancer and infectious diseases, and these There are many different characteristics between therapy and traditional therapy, including its ability to expand and contract as needed, and to adjust the therapeutic effect of the body within a few months or years after a single application; due to basic immunology, gene function, gene editing With the continuous application and progress of synthetic biology, the complexity of immune cell therapy has been greatly expanded, which can improve the effectiveness and safety of immune cell therapy, and also increase its potential for treating diseases.

According to our (Global Info Research) latest study, the global Cell and Gene Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Cell and Gene Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Cell and Gene Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
Global Cell and Gene Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Cell and Gene Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Cell and Gene Therapy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cell and Gene Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cell and Gene Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen Inc., bluebird bio, Inc., Dendreon Pharmaceuticals LLC., Fibrocell Science, Inc. and Human Stem Cells Institute, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Cell and Gene Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Rare Diseases
    Oncology
    Hematology
    Cardiovascular
    Ophthalmology
    Neurology
    Other Therapeutic Classes

Market segment by Application
    Pharmaceutical and Biotechnology Companies
    Research and Academic Institutions
    Contract Research Organizations (CROs)
    Hospital
    Others

Market segment by players, this report covers
    Amgen Inc.
    bluebird bio, Inc.
    Dendreon Pharmaceuticals LLC.
    Fibrocell Science, Inc.
    Human Stem Cells Institute
    Kite Pharma, Inc.
    Kolon TissueGene, Inc.
    Novartis AG
    Orchard Therapeutics plc.
    Organogenesis Holdings Inc.
    Pfizer, Inc.
    RENOVA THERAPEUTICS
    Shanghai Sunway Biotech Co., Ltd.,
    Sibiono GeneTech Co. Ltd.,
    Spark Therapeutics, Inc.
    Vericel Corporation
    ViroMed Co., Ltd.

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cell and Gene Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell and Gene Therapy, with revenue, gross margin and global market share of Cell and Gene Therapy from 2018 to 2023.
Chapter 3, the Cell and Gene Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Cell and Gene Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell and Gene Therapy.
Chapter 13, to describe Cell and Gene Therapy research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Cell and Gene Therapy
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Cell and Gene Therapy by Type
        1.3.1 Overview: Global Cell and Gene Therapy Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Cell and Gene Therapy Consumption Value Market Share by Type in 2022
        1.3.3 Rare Diseases
        1.3.4 Oncology
        1.3.5 Hematology
        1.3.6 Cardiovascular
        1.3.7 Ophthalmology
        1.3.8 Neurology
        1.3.9 Other Therapeutic Classes
    1.4 Global Cell and Gene Therapy Market by Application
        1.4.1 Overview: Global Cell and Gene Therapy Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Pharmaceutical and Biotechnology Companies
        1.4.3 Research and Academic Institutions
        1.4.4 Contract Research Organizations (CROs)
        1.4.5 Hospital
        1.4.6 Others
    1.5 Global Cell and Gene Therapy Market Size & Forecast
    1.6 Global Cell and Gene Therapy Market Size and Forecast by Region
        1.6.1 Global Cell and Gene Therapy Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Cell and Gene Therapy Market Size by Region, (2018-2029)
        1.6.3 North America Cell and Gene Therapy Market Size and Prospect (2018-2029)
        1.6.4 Europe Cell and Gene Therapy Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Cell and Gene Therapy Market Size and Prospect (2018-2029)
        1.6.6 South America Cell and Gene Therapy Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Cell and Gene Therapy Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Amgen Inc.
        2.1.1 Amgen Inc. Details
        2.1.2 Amgen Inc. Major Business
        2.1.3 Amgen Inc. Cell and Gene Therapy Product and Solutions
        2.1.4 Amgen Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Amgen Inc. Recent Developments and Future Plans
    2.2 bluebird bio, Inc.
        2.2.1 bluebird bio, Inc. Details
        2.2.2 bluebird bio, Inc. Major Business
        2.2.3 bluebird bio, Inc. Cell and Gene Therapy Product and Solutions
        2.2.4 bluebird bio, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 bluebird bio, Inc. Recent Developments and Future Plans
    2.3 Dendreon Pharmaceuticals LLC.
        2.3.1 Dendreon Pharmaceuticals LLC. Details
        2.3.2 Dendreon Pharmaceuticals LLC. Major Business
        2.3.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Product and Solutions
        2.3.4 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Dendreon Pharmaceuticals LLC. Recent Developments and Future Plans
    2.4 Fibrocell Science, Inc.
        2.4.1 Fibrocell Science, Inc. Details
        2.4.2 Fibrocell Science, Inc. Major Business
        2.4.3 Fibrocell Science, Inc. Cell and Gene Therapy Product and Solutions
        2.4.4 Fibrocell Science, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Fibrocell Science, Inc. Recent Developments and Future Plans
    2.5 Human Stem Cells Institute
        2.5.1 Human Stem Cells Institute Details
        2.5.2 Human Stem Cells Institute Major Business
        2.5.3 Human Stem Cells Institute Cell and Gene Therapy Product and Solutions
        2.5.4 Human Stem Cells Institute Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Human Stem Cells Institute Recent Developments and Future Plans
    2.6 Kite Pharma, Inc.
        2.6.1 Kite Pharma, Inc. Details
        2.6.2 Kite Pharma, Inc. Major Business
        2.6.3 Kite Pharma, Inc. Cell and Gene Therapy Product and Solutions
        2.6.4 Kite Pharma, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Kite Pharma, Inc. Recent Developments and Future Plans
    2.7 Kolon TissueGene, Inc.
        2.7.1 Kolon TissueGene, Inc. Details
        2.7.2 Kolon TissueGene, Inc. Major Business
        2.7.3 Kolon TissueGene, Inc. Cell and Gene Therapy Product and Solutions
        2.7.4 Kolon TissueGene, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Kolon TissueGene, Inc. Recent Developments and Future Plans
    2.8 Novartis AG
        2.8.1 Novartis AG Details
        2.8.2 Novartis AG Major Business
        2.8.3 Novartis AG Cell and Gene Therapy Product and Solutions
        2.8.4 Novartis AG Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Novartis AG Recent Developments and Future Plans
    2.9 Orchard Therapeutics plc.
        2.9.1 Orchard Therapeutics plc. Details
        2.9.2 Orchard Therapeutics plc. Major Business
        2.9.3 Orchard Therapeutics plc. Cell and Gene Therapy Product and Solutions
        2.9.4 Orchard Therapeutics plc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Orchard Therapeutics plc. Recent Developments and Future Plans
    2.10 Organogenesis Holdings Inc.
        2.10.1 Organogenesis Holdings Inc. Details
        2.10.2 Organogenesis Holdings Inc. Major Business
        2.10.3 Organogenesis Holdings Inc. Cell and Gene Therapy Product and Solutions
        2.10.4 Organogenesis Holdings Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Organogenesis Holdings Inc. Recent Developments and Future Plans
    2.11 Pfizer, Inc.
        2.11.1 Pfizer, Inc. Details
        2.11.2 Pfizer, Inc. Major Business
        2.11.3 Pfizer, Inc. Cell and Gene Therapy Product and Solutions
        2.11.4 Pfizer, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Pfizer, Inc. Recent Developments and Future Plans
    2.12 RENOVA THERAPEUTICS
        2.12.1 RENOVA THERAPEUTICS Details
        2.12.2 RENOVA THERAPEUTICS Major Business
        2.12.3 RENOVA THERAPEUTICS Cell and Gene Therapy Product and Solutions
        2.12.4 RENOVA THERAPEUTICS Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 RENOVA THERAPEUTICS Recent Developments and Future Plans
    2.13 Shanghai Sunway Biotech Co., Ltd.,
        2.13.1 Shanghai Sunway Biotech Co., Ltd., Details
        2.13.2 Shanghai Sunway Biotech Co., Ltd., Major Business
        2.13.3 Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Product and Solutions
        2.13.4 Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Shanghai Sunway Biotech Co., Ltd., Recent Developments and Future Plans
    2.14 Sibiono GeneTech Co. Ltd.,
        2.14.1 Sibiono GeneTech Co. Ltd., Details
        2.14.2 Sibiono GeneTech Co. Ltd., Major Business
        2.14.3 Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Product and Solutions
        2.14.4 Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Sibiono GeneTech Co. Ltd., Recent Developments and Future Plans
    2.15 Spark Therapeutics, Inc.
        2.15.1 Spark Therapeutics, Inc. Details
        2.15.2 Spark Therapeutics, Inc. Major Business
        2.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Product and Solutions
        2.15.4 Spark Therapeutics, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Spark Therapeutics, Inc. Recent Developments and Future Plans
    2.16 Vericel Corporation
        2.16.1 Vericel Corporation Details
        2.16.2 Vericel Corporation Major Business
        2.16.3 Vericel Corporation Cell and Gene Therapy Product and Solutions
        2.16.4 Vericel Corporation Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.16.5 Vericel Corporation Recent Developments and Future Plans
    2.17 ViroMed Co., Ltd.
        2.17.1 ViroMed Co., Ltd. Details
        2.17.2 ViroMed Co., Ltd. Major Business
        2.17.3 ViroMed Co., Ltd. Cell and Gene Therapy Product and Solutions
        2.17.4 ViroMed Co., Ltd. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.17.5 ViroMed Co., Ltd. Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Cell and Gene Therapy Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Cell and Gene Therapy by Company Revenue
        3.2.2 Top 3 Cell and Gene Therapy Players Market Share in 2022
        3.2.3 Top 6 Cell and Gene Therapy Players Market Share in 2022
    3.3 Cell and Gene Therapy Market: Overall Company Footprint Analysis
        3.3.1 Cell and Gene Therapy Market: Region Footprint
        3.3.2 Cell and Gene Therapy Market: Company Product Type Footprint
        3.3.3 Cell and Gene Therapy Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Cell and Gene Therapy Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Cell and Gene Therapy Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Cell and Gene Therapy Consumption Value Market Share by Application (2018-2023)
    5.2 Global Cell and Gene Therapy Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Cell and Gene Therapy Consumption Value by Type (2018-2029)
    6.2 North America Cell and Gene Therapy Consumption Value by Application (2018-2029)
    6.3 North America Cell and Gene Therapy Market Size by Country
        6.3.1 North America Cell and Gene Therapy Consumption Value by Country (2018-2029)
        6.3.2 United States Cell and Gene Therapy Market Size and Forecast (2018-2029)
        6.3.3 Canada Cell and Gene Therapy Market Size and Forecast (2018-2029)
        6.3.4 Mexico Cell and Gene Therapy Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Cell and Gene Therapy Consumption Value by Type (2018-2029)
    7.2 Europe Cell and Gene Therapy Consumption Value by Application (2018-2029)
    7.3 Europe Cell and Gene Therapy Market Size by Country
        7.3.1 Europe Cell and Gene Therapy Consumption Value by Country (2018-2029)
        7.3.2 Germany Cell and Gene Therapy Market Size and Forecast (2018-2029)
        7.3.3 France Cell and Gene Therapy Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Cell and Gene Therapy Market Size and Forecast (2018-2029)
        7.3.5 Russia Cell and Gene Therapy Market Size and Forecast (2018-2029)
        7.3.6 Italy Cell and Gene Therapy Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Cell and Gene Therapy Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Cell and Gene Therapy Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Cell and Gene Therapy Market Size by Region
        8.3.1 Asia-Pacific Cell and Gene Therapy Consumption Value by Region (2018-2029)
        8.3.2 China Cell and Gene Therapy Market Size and Forecast (2018-2029)
        8.3.3 Japan Cell and Gene Therapy Market Size and Forecast (2018-2029)
        8.3.4 South Korea Cell and Gene Therapy Market Size and Forecast (2018-2029)
        8.3.5 India Cell and Gene Therapy Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Cell and Gene Therapy Market Size and Forecast (2018-2029)
        8.3.7 Australia Cell and Gene Therapy Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Cell and Gene Therapy Consumption Value by Type (2018-2029)
    9.2 South America Cell and Gene Therapy Consumption Value by Application (2018-2029)
    9.3 South America Cell and Gene Therapy Market Size by Country
        9.3.1 South America Cell and Gene Therapy Consumption Value by Country (2018-2029)
        9.3.2 Brazil Cell and Gene Therapy Market Size and Forecast (2018-2029)
        9.3.3 Argentina Cell and Gene Therapy Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Cell and Gene Therapy Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Cell and Gene Therapy Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Cell and Gene Therapy Market Size by Country
        10.3.1 Middle East & Africa Cell and Gene Therapy Consumption Value by Country (2018-2029)
        10.3.2 Turkey Cell and Gene Therapy Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Cell and Gene Therapy Market Size and Forecast (2018-2029)
        10.3.4 UAE Cell and Gene Therapy Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Cell and Gene Therapy Market Drivers
    11.2 Cell and Gene Therapy Market Restraints
    11.3 Cell and Gene Therapy Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Cell and Gene Therapy Industry Chain
    12.2 Cell and Gene Therapy Upstream Analysis
    12.3 Cell and Gene Therapy Midstream Analysis
    12.4 Cell and Gene Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Cell and Gene Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Cell and Gene Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Cell and Gene Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Cell and Gene Therapy Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Amgen Inc. Company Information, Head Office, and Major Competitors
    Table 6. Amgen Inc. Major Business
    Table 7. Amgen Inc. Cell and Gene Therapy Product and Solutions
    Table 8. Amgen Inc. Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Amgen Inc. Recent Developments and Future Plans
    Table 10. bluebird bio, Inc. Company Information, Head Office, and Major Competitors
    Table 11. bluebird bio, Inc. Major Business
    Table 12. bluebird bio, Inc. Cell and Gene Therapy Product and Solutions
    Table 13. bluebird bio, Inc. Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. bluebird bio, Inc. Recent Developments and Future Plans
    Table 15. Dendreon Pharmaceuticals LLC. Company Information, Head Office, and Major Competitors
    Table 16. Dendreon Pharmaceuticals LLC. Major Business
    Table 17. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Product and Solutions
    Table 18. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Dendreon Pharmaceuticals LLC. Recent Developments and Future Plans
    Table 20. Fibrocell Science, Inc. Company Information, Head Office, and Major Competitors
    Table 21. Fibrocell Science, Inc. Major Business
    Table 22. Fibrocell Science, Inc. Cell and Gene Therapy Product and Solutions
    Table 23. Fibrocell Science, Inc. Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Fibrocell Science, Inc. Recent Developments and Future Plans
    Table 25. Human Stem Cells Institute Company Information, Head Office, and Major Competitors
    Table 26. Human Stem Cells Institute Major Business
    Table 27. Human Stem Cells Institute Cell and Gene Therapy Product and Solutions
    Table 28. Human Stem Cells Institute Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Human Stem Cells Institute Recent Developments and Future Plans
    Table 30. Kite Pharma, Inc. Company Information, Head Office, and Major Competitors
    Table 31. Kite Pharma, Inc. Major Business
    Table 32. Kite Pharma, Inc. Cell and Gene Therapy Product and Solutions
    Table 33. Kite Pharma, Inc. Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Kite Pharma, Inc. Recent Developments and Future Plans
    Table 35. Kolon TissueGene, Inc. Company Information, Head Office, and Major Competitors
    Table 36. Kolon TissueGene, Inc. Major Business
    Table 37. Kolon TissueGene, Inc. Cell and Gene Therapy Product and Solutions
    Table 38. Kolon TissueGene, Inc. Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Kolon TissueGene, Inc. Recent Developments and Future Plans
    Table 40. Novartis AG Company Information, Head Office, and Major Competitors
    Table 41. Novartis AG Major Business
    Table 42. Novartis AG Cell and Gene Therapy Product and Solutions
    Table 43. Novartis AG Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Novartis AG Recent Developments and Future Plans
    Table 45. Orchard Therapeutics plc. Company Information, Head Office, and Major Competitors
    Table 46. Orchard Therapeutics plc. Major Business
    Table 47. Orchard Therapeutics plc. Cell and Gene Therapy Product and Solutions
    Table 48. Orchard Therapeutics plc. Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Orchard Therapeutics plc. Recent Developments and Future Plans
    Table 50. Organogenesis Holdings Inc. Company Information, Head Office, and Major Competitors
    Table 51. Organogenesis Holdings Inc. Major Business
    Table 52. Organogenesis Holdings Inc. Cell and Gene Therapy Product and Solutions
    Table 53. Organogenesis Holdings Inc. Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Organogenesis Holdings Inc. Recent Developments and Future Plans
    Table 55. Pfizer, Inc. Company Information, Head Office, and Major Competitors
    Table 56. Pfizer, Inc. Major Business
    Table 57. Pfizer, Inc. Cell and Gene Therapy Product and Solutions
    Table 58. Pfizer, Inc. Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Pfizer, Inc. Recent Developments and Future Plans
    Table 60. RENOVA THERAPEUTICS Company Information, Head Office, and Major Competitors
    Table 61. RENOVA THERAPEUTICS Major Business
    Table 62. RENOVA THERAPEUTICS Cell and Gene Therapy Product and Solutions
    Table 63. RENOVA THERAPEUTICS Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. RENOVA THERAPEUTICS Recent Developments and Future Plans
    Table 65. Shanghai Sunway Biotech Co., Ltd., Company Information, Head Office, and Major Competitors
    Table 66. Shanghai Sunway Biotech Co., Ltd., Major Business
    Table 67. Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Product and Solutions
    Table 68. Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. Shanghai Sunway Biotech Co., Ltd., Recent Developments and Future Plans
    Table 70. Sibiono GeneTech Co. Ltd., Company Information, Head Office, and Major Competitors
    Table 71. Sibiono GeneTech Co. Ltd., Major Business
    Table 72. Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Product and Solutions
    Table 73. Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 74. Sibiono GeneTech Co. Ltd., Recent Developments and Future Plans
    Table 75. Spark Therapeutics, Inc. Company Information, Head Office, and Major Competitors
    Table 76. Spark Therapeutics, Inc. Major Business
    Table 77. Spark Therapeutics, Inc. Cell and Gene Therapy Product and Solutions
    Table 78. Spark Therapeutics, Inc. Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 79. Spark Therapeutics, Inc. Recent Developments and Future Plans
    Table 80. Vericel Corporation Company Information, Head Office, and Major Competitors
    Table 81. Vericel Corporation Major Business
    Table 82. Vericel Corporation Cell and Gene Therapy Product and Solutions
    Table 83. Vericel Corporation Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 84. Vericel Corporation Recent Developments and Future Plans
    Table 85. ViroMed Co., Ltd. Company Information, Head Office, and Major Competitors
    Table 86. ViroMed Co., Ltd. Major Business
    Table 87. ViroMed Co., Ltd. Cell and Gene Therapy Product and Solutions
    Table 88. ViroMed Co., Ltd. Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. ViroMed Co., Ltd. Recent Developments and Future Plans
    Table 90. Global Cell and Gene Therapy Revenue (USD Million) by Players (2018-2023)
    Table 91. Global Cell and Gene Therapy Revenue Share by Players (2018-2023)
    Table 92. Breakdown of Cell and Gene Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 93. Market Position of Players in Cell and Gene Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 94. Head Office of Key Cell and Gene Therapy Players
    Table 95. Cell and Gene Therapy Market: Company Product Type Footprint
    Table 96. Cell and Gene Therapy Market: Company Product Application Footprint
    Table 97. Cell and Gene Therapy New Market Entrants and Barriers to Market Entry
    Table 98. Cell and Gene Therapy Mergers, Acquisition, Agreements, and Collaborations
    Table 99. Global Cell and Gene Therapy Consumption Value (USD Million) by Type (2018-2023)
    Table 100. Global Cell and Gene Therapy Consumption Value Share by Type (2018-2023)
    Table 101. Global Cell and Gene Therapy Consumption Value Forecast by Type (2024-2029)
    Table 102. Global Cell and Gene Therapy Consumption Value by Application (2018-2023)
    Table 103. Global Cell and Gene Therapy Consumption Value Forecast by Application (2024-2029)
    Table 104. North America Cell and Gene Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 105. North America Cell and Gene Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 106. North America Cell and Gene Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 107. North America Cell and Gene Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 108. North America Cell and Gene Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 109. North America Cell and Gene Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 110. Europe Cell and Gene Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 111. Europe Cell and Gene Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 112. Europe Cell and Gene Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 113. Europe Cell and Gene Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 114. Europe Cell and Gene Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 115. Europe Cell and Gene Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 116. Asia-Pacific Cell and Gene Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 117. Asia-Pacific Cell and Gene Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 118. Asia-Pacific Cell and Gene Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 119. Asia-Pacific Cell and Gene Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 120. Asia-Pacific Cell and Gene Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 121. Asia-Pacific Cell and Gene Therapy Consumption Value by Region (2024-2029) & (USD Million)
    Table 122. South America Cell and Gene Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 123. South America Cell and Gene Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 124. South America Cell and Gene Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 125. South America Cell and Gene Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 126. South America Cell and Gene Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 127. South America Cell and Gene Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 128. Middle East & Africa Cell and Gene Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 129. Middle East & Africa Cell and Gene Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 130. Middle East & Africa Cell and Gene Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 131. Middle East & Africa Cell and Gene Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 132. Middle East & Africa Cell and Gene Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 133. Middle East & Africa Cell and Gene Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 134. Cell and Gene Therapy Raw Material
    Table 135. Key Suppliers of Cell and Gene Therapy Raw Materials
List of Figures
    Figure 1. Cell and Gene Therapy Picture
    Figure 2. Global Cell and Gene Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Cell and Gene Therapy Consumption Value Market Share by Type in 2022
    Figure 4. Rare Diseases
    Figure 5. Oncology
    Figure 6. Hematology
    Figure 7. Cardiovascular
    Figure 8. Ophthalmology
    Figure 9. Neurology
    Figure 10. Other Therapeutic Classes
    Figure 11. Global Cell and Gene Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 12. Cell and Gene Therapy Consumption Value Market Share by Application in 2022
    Figure 13. Pharmaceutical and Biotechnology Companies Picture
    Figure 14. Research and Academic Institutions Picture
    Figure 15. Contract Research Organizations (CROs) Picture
    Figure 16. Hospital Picture
    Figure 17. Others Picture
    Figure 18. Global Cell and Gene Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 19. Global Cell and Gene Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 20. Global Market Cell and Gene Therapy Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 21. Global Cell and Gene Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 22. Global Cell and Gene Therapy Consumption Value Market Share by Region in 2022
    Figure 23. North America Cell and Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 24. Europe Cell and Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 25. Asia-Pacific Cell and Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 26. South America Cell and Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 27. Middle East and Africa Cell and Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 28. Global Cell and Gene Therapy Revenue Share by Players in 2022
    Figure 29. Cell and Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 30. Global Top 3 Players Cell and Gene Therapy Market Share in 2022
    Figure 31. Global Top 6 Players Cell and Gene Therapy Market Share in 2022
    Figure 32. Global Cell and Gene Therapy Consumption Value Share by Type (2018-2023)
    Figure 33. Global Cell and Gene Therapy Market Share Forecast by Type (2024-2029)
    Figure 34. Global Cell and Gene Therapy Consumption Value Share by Application (2018-2023)
    Figure 35. Global Cell and Gene Therapy Market Share Forecast by Application (2024-2029)
    Figure 36. North America Cell and Gene Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 37. North America Cell and Gene Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 38. North America Cell and Gene Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 39. United States Cell and Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 40. Canada Cell and Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 41. Mexico Cell and Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 42. Europe Cell and Gene Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 43. Europe Cell and Gene Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 44. Europe Cell and Gene Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 45. Germany Cell and Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 46. France Cell and Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 47. United Kingdom Cell and Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 48. Russia Cell and Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 49. Italy Cell and Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 50. Asia-Pacific Cell and Gene Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 51. Asia-Pacific Cell and Gene Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 52. Asia-Pacific Cell and Gene Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 53. China Cell and Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 54. Japan Cell and Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 55. South Korea Cell and Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 56. India Cell and Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 57. Southeast Asia Cell and Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 58. Australia Cell and Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 59. South America Cell and Gene Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 60. South America Cell and Gene Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 61. South America Cell and Gene Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 62. Brazil Cell and Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 63. Argentina Cell and Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 64. Middle East and Africa Cell and Gene Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 65. Middle East and Africa Cell and Gene Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 66. Middle East and Africa Cell and Gene Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 67. Turkey Cell and Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 68. Saudi Arabia Cell and Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 69. UAE Cell and Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 70. Cell and Gene Therapy Market Drivers
    Figure 71. Cell and Gene Therapy Market Restraints
    Figure 72. Cell and Gene Therapy Market Trends
    Figure 73. Porters Five Forces Analysis
    Figure 74. Manufacturing Cost Structure Analysis of Cell and Gene Therapy in 2022
    Figure 75. Manufacturing Process Analysis of Cell and Gene Therapy
    Figure 76. Cell and Gene Therapy Industrial Chain
    Figure 77. Methodology
    Figure 78. Research Process and Data Source

Companies Mentioned

Amgen Inc.
bluebird bio, Inc.
Dendreon Pharmaceuticals LLC.
Fibrocell Science, Inc.
Human Stem Cells Institute
Kite Pharma, Inc.
Kolon TissueGene, Inc.
Novartis AG
Orchard Therapeutics plc.
Organogenesis Holdings Inc.
Pfizer, Inc.
RENOVA THERAPEUTICS
Shanghai Sunway Biotech Co., Ltd.,
Sibiono GeneTech Co. Ltd.,
Spark Therapeutics, Inc.
Vericel Corporation
ViroMed Co., Ltd.